XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Discontinued Operations (Tables)
 12 Months Ended
Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Discontinued Operations
The following table summarizes the major classes of assets and liabilities related to the discontinued operations of the TransCore and Zetec businesses as reported in the Consolidated Balance Sheets at December 31:

December 31,
2021 (1)
Accounts receivable, net$74.7 
Inventories, net47.8 
Unbilled receivables158.2 
Goodwill405.5 
Other intangible assets, net31.0 
Other current assets71.4 
Current assets held for sale$788.6 
Accounts payable$40.3 
Accrued compensation27.0 
Deferred taxes29.5 
Other current liabilities62.3 
Current liabilities held for sale$159.1 
(1) All assets and liabilities held for sale were classified as current as it was probable that the sale of TransCore and Zetec would be completed within one year from the balance sheet date.
The following table summarizes the major classes of revenue and expenses constituting net earnings from discontinued operations attributable to the TransCore, Zetec and CIVCO Radiotherapy businesses:

Year ended December 31,
202220212020
Net revenues$100.4 $638.0 $672.9 
Cost of sales71.2372.9400.7
Gross profit29.2265.1272.2
Selling, general and administrative expenses (1)
19.9124.0114.6
Income from operations9.3141.1157.6
Other income, net0.11.50.3
Earnings before income taxes (2)
9.4142.6157.9
Income taxes(6.2)28.533.7
Earnings from discontinued operations, net of tax15.6114.1124.2
Gain on disposition of discontinued operations, net of tax (3)
1,717.555.9—
Net earnings from discontinued operations$1,733.1 $170.0 $124.2 
(1) Includes stock-based compensation expense of $0.9, $5.4 and $4.8 for the years ended December 31, 2022, 2021, and 2020, respectively. Stock-based compensation for discontinued operations was previously reported as a component of unallocated corporate general and administrative expenses.
(2) During the year ended December 31, 2022, there was no depreciation of property, plant and equipment or amortization of intangible assets given the asset classification as held for sale during the period. Depreciation and amortization of $5.2 and $7.9 for the years ended December 31, 2021, and 2020, respectively.
(3) In connection with the 2021 Divestitures, we recognized $4.5 and $0.9 associated with accelerated vesting of share-based awards for the years ended December 31, 2022 and 2021, respectively.
The following table summarizes the major classes of assets and liabilities related to the discontinued operations of Indicor, as reported in the Consolidated Balance Sheets:
December 31, 2021
Accounts receivable, net$151.8 
Inventories, net106.9 
Other current assets30.7 
Current assets held for sale$289.4 
Goodwill618.2 
Other intangible assets, net79.4 
Deferred taxes51.1 
Other assets56.2 
Assets held for sale$804.9 
Accounts payable$52.5 
Accrued compensation47.9 
Deferred revenue23.9 
Income taxes payable14.7 
Other current liabilities42.0 
Current liabilities held for sale$181.0 
Deferred taxes$13.3 
Noncurrent operating lease liabilities24.1 
Other liabilities12.0 
Liabilities held for sale$49.4 
The following table summarizes the major classes of revenue and expenses constituting net earnings from discontinued operations attributable to Indicor:

Year ended December 31,
202220212020
Net revenues$916.1 $944.0 $831.8 
Cost of sales432.1434.2389.3
Gross profit484.0509.8442.5
Selling, general and administrative expenses(1)
250.5265.7251.9
Impairment of intangible assets—5.1—
Income from operations233.5239.0190.6
Other income (expense), net(0.7)0.1(0.5)
Earnings before income taxes (2)
232.8239.1190.1
Income taxes45.661.838.4
Earnings from discontinued operations, net of tax187.2177.3151.7
Gain on disposition of discontinued operations, net of tax1,638.8——
Net earnings from discontinued operations$1,826.0 $177.3 $151.7 
(1) Certain costs previously reported as a component of unallocated corporate general and administrative expenses have been reclassified to discontinued operations. These costs primarily include stock-based compensation expense of $10.3, $13.1, and $8.7 for the years ended December 31, 2022, 2021, and 2020, respectively.
(2) Includes depreciation and amortization of $6.4, $18.2 and $21.3 for the years ended December 31, 2022, 2021, and 2020, respectively.